Haoming Xu

机构：Guangzhou First People's Hospital, Guangdong Provincial People's Hospital, Guangzhou Medical University · ORCID：0000-0002-8131-7477

发表论文 115 篇 · 总被引 3653 次 · h-index 34

代表论文

• Houttuynia cordata-Derived Exosome-Like Nanoparticles Mitigate Colitis in Mice via Inhibition of the NLRP3 Signaling Pathway and Modulation of the Gut Microbiota (2024 · International Journal of Nanomedicine · 被引 47)
• Roles of the gut microbiota in hepatocellular carcinoma: from the gut dysbiosis to the intratumoral microbiota (2025 · Cell Death Discovery · 被引 46)
• Odoribacter splanchnicus—A Next-Generation Probiotic Candidate (2025 · Microorganisms · 被引 32)
• Engineered probiotics: a new era in treating inflammatory bowel disease (2025 · Journal of Translational Medicine · 被引 18)
• The key players of inflammasomes and pyroptosis in sepsis-induced pathogenesis and organ dysfunction (2025 · Frontiers in Pharmacology · 被引 18)
• Secondary Bile Acids Modified by Odoribacter Splanchnicus Alleviate Colitis by Suppressing Neutrophil Extracellular Trap Formation (2025 · Advanced Science · 被引 13)